Public Reporting

ACO Name & Location

Emergent ACO 23.1, LLC
2323 N. John B Dennis Hwy
Kingsport, TN 37660

ACO Primary Contact

Primary Contact Name: Scott R. Fowler, J.D., M.D.
Primary Contact Phone: 423-857-2091
Primary Contact Email: scott.fowler@myhmg.com

Organizational Information
ACO Participants:
ACO Participants ACO Participant
in Joint Venture
(Enter Y or N)
Bloomfield Medical Clinic PC Y
Butler County Clinic, PC Y
Central Nebraska Medical Clinic, PC Y
Complete Family Medicine LLC Y
Falls City Family Practice, PC Y
Family Medical Center of Hastings Y
Fillmore County Medical Center, PC Y
Midlands Family Medicine Y
Plum Creek Medical Group P.C. Y
Med Express of Alabama LLC Y
Med Express of Tennessee LLC Y
Abingdon Family Healthcare, Inc. Y
Abingdon Internal Medicine PC Y
Grace Family Medicine Clinic LLC Y
Internal Medicine and Pediatric Associates of Bristol Y
Integrated Health Concepts, LLC Y
Karing Hearts Cardiology, PC Y
Newport Internal Medicine, PC Y
Upper Cumberland Rural Health, PLLC Y
ACO Governing Body:
Name Title Voting Power Membership Type TIN Legal Business Name
Scott R. Fowler, J.D., M.D. Director/President 10.0% Other OnePartner Health Solutions, LLC
Pushpendra Jain, M.D. Director 10.0% ACO Participant Representative Upper Cumberland Rural Health
Joy Hamilton, M.D. Director 10.0% ACO Participant Representative Upper Cumberland Rural Health
Racheal Gordon Director 10.0% ACO Participant Representative Express Med of Tennessee, LLC
James H. Schrendker, M.D. Director 10.0% ACO Participant Representative Integrated Health Concepts, LLC
Jennifer A. Jonkers, M.D. Director 10.0% ACO Participant Representative Abingdon Internal Medicine PC
David Minnick, M.C. Director 10.0% ACO Representative Central Nebraska Medical Clinic, P.C.
Allan Tramp, M.D. Director 10.0% ACO Participant Representative Falls City Family Practice, P.C.
Joshua Sypal, M.D. Director 10.0% ACO Participant Representative Butler County Clinic, PC
Brenda Daniel Director 10.0% Medicare Beneficiary Representative Medicare Beneficiary Representative
Key ACO Clinical & Administrative Leadership:
ACO Executive: Scott R. Fowler, J.D., M.D.
Medical Director: Shelton L. Hager, M.D.
Compliance Officer: Cheryl Stanski, M.D.
Quality Assurance/Improvement Officer: Samantha Sizemore, COO
Associated Committees & Committee Leadership:
Committee Name Committee Leader Name and Position
Clinical Transformation Committee Shelton Hager, MD – Committee Chair
Operations, Quality, Clinical Process, and Population Health Improvement Committee Samantha Sizemore, COO – Committee Chair
Beneficiary Engagement Committee Samantha Sizemore, COO – Committee Chair
Communications & Marketing Committee Samantha Sizemore, COO – Committee Chair
Technology & Data Analytics Committee Byron Sayler – Committee Chair
Contracting & Finance Committee Shawna Armstrong, Treasurer – Committee Co-Chair
Randall Sermons – Co-Chair
Compliance Committee Cheryl Stantski, M.D. – Committee Chair
Types of ACO Participants, or Combinations of Participants, that Formed the ACO:
  • Networks of individual practices of ACO professionals
Shared Savings and Losses
Amount of Shared Savings/Losses
  • Second Agreement Period
    • Performance Year 2024 – January 1, 2024 – December 31, 2024 – TBD
  • First Agreement Period
    • Performance Year 2023 – January 1, 2023 – December 31, 2023 – $0.00
Shared Savings Distribution
  • Second Agreement Period
    • Performance Year 2024 – Janauary 1, 2024 – December 31, 2024
      • Proportion invested in infrastructure: TBD
      • Proportion invested in redesigned care processes/resources: TBD
      • Proportion of distribution to ACO participants: TBD
  • First Agreement Period
    • Performance Year 2023 – Janauary 1, 2023 – December 31, 2023
      • Proportion invested in infrastructure: $0.00
      • Proportion invested in redesigned care processes/resources: $0.00
      • Proportion of distribution to ACO participants: $0.00
Quality Performance Results

2023 Quality Performance Results:

ACO Quality
Measure Number
Measure Name Rate ACO Mean
001 Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) [1] 8.33 9.84
134 Preventive Care and Screening: Screening for Depression and Follow-up Plan 88.82 80.97
236 Controlling High Blood Pressure 84.62 77.80
318 Falls: Screening for Future Fall Risk 91.76 89.42
110 Preventive Care and Screening: Influenza Immunization 82.19 70.76
226 Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 100.00 79.29
113 Colorectal Cancer Screening 86.66 77.14
112 Breast Cancer Screening 84.55 80.36
438 Statin Theraphy for the Prvention and Treatment of Cardiovascular Disease 84.56 87.05
370 Depression Remission at Twelve Months 33.33 16.58
321 CAHPS for MIPS 7.47 6.25
479 Hospital Wide 30 Day, All-Cause Readmission HWR Rate for MIPS Groups 0.1402 0.1553
484 Clinician and Clinician Group Risk-standardized Hospital Admission Rates for Patients with Multiple Chronic Conditions [1] 35.89
CAPHS Number Measure Name Rate ACO Mean
CAHPS-1 Getting Timely Care, Appointments, and Information 82.25 83.68
CAHPS-2 How Well Providers Communicate 92.94 93.69
CAHPS-3 Patient’s Rating of Provider 92.38 92.14
CAHPS-4 Access to Specialists 79.84 75.97
CAHPS-5 Health Promotion and Education 62.57 63.93
CAHPS-6 Shared Decision Making 64.68 61.60
CAHPS-7 Health Status and Functional Status 75.02 74.12
CAHPS-8 Care Coordination 87.08 85.77
CAHPS-9 Courteous and Helpful Office Staff 93.79 92.31
CAHPS-11 Stewardship of Patient Resources 30.96 26.69
  • Please also note that per CMS policy, you should not publicly share or report cell sizes <11 or any combination of information that would allow cell sizes of <11 to be calculated.

For Previous years’ Financial and Quality Performance Results, please visit: http://data.cms.gov

Payment Rule Waivers
  • Waiver for Payment for Telehealth Services:
    • Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.
  • Fraud and Abuse Waivers
    • ACO Participation Waiver:

      The following information describes each arrangement for which our ACO seeks protection under the ACO Participation Waiver, including any material amendment or modification to a disclosed arrangement.

      • Parties to the arrangement: Emergent ACO, LLC and Quest Diagnostics, Inc.
      • Date of arrangement: 01/01/2023
      • Items, services, goods, or facility provided: Services
      • No Amendments
      • Summary of Arrangement Conducted Under the ACO Participation Waiver


Last updated on November 27, 2024